ReviewOncology reports2025

Harnessing CRISPR/Cas9 to overcome targeted therapy resistance in non‑small cell lung cancer: Advances and challenges (Review).

Jianting Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.